Hyperfine (HYPR) Other Accumulated Expenses (2020 - 2026)
Hyperfine (HYPR) posted Other Accumulated Expenses of $328000.0 for Q1 2026, down 28.7% on a QoQ basis from $460000.0 in Q4 2025, and up 94.08% year-over-year from $169000.0 in Q1 2025.
Hyperfine (HYPR) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Hyperfine's Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $328000.0 for Q1 2026.
- Quarterly Other Accumulated Expenses rose 94.08% year-over-year to $328000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $328000.0 (up 94.08% YoY) and the FY2025 annual result came in at $460000.0, down 2.75% from the prior year.
- Other Accumulated Expenses was $328000.0 for Q1 2026 at Hyperfine, down from $460000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $648000.0 in Q3 2024 and bottomed at $38000.0 in Q4 2022.
- A 5-year average of $277588.2 and a median of $241000.0 in 2024 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2023 — Other Accumulated Expenses soared 1073.68% — and 2025, when it tumbled 60.34%.
- Hyperfine's Other Accumulated Expenses stood at $38000.0 in 2022, then surged by 1073.68% to $446000.0 in 2023, then rose by 6.05% to $473000.0 in 2024, then decreased by 2.75% to $460000.0 in 2025, then fell by 28.7% to $328000.0 in 2026.
- Business Quant data shows HYPR's Other Accumulated Expenses at $328000.0 in Q1 2026, $460000.0 in Q4 2025, and $257000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Hyperfine | 92.81 Mn | 51.53 Mn | 1.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 328,000.00 |
| Dec 31, 2025 | 460,000.00 |
| Sep 30, 2025 | 257,000.00 |
| Jun 30, 2025 | 225,000.00 |
| Mar 31, 2025 | 169,000.00 |
| Dec 31, 2024 | 473,000.00 |
| Sep 30, 2024 | 648,000.00 |
| Jun 30, 2024 | 241,000.00 |
| Mar 31, 2024 | 157,000.00 |
| Dec 31, 2023 | 446,000.00 |
| Sep 30, 2023 | 375,000.00 |
| Jun 30, 2023 | 183,000.00 |
| Mar 31, 2023 | 332,000.00 |
| Dec 31, 2022 | 38,000.00 |
| Sep 30, 2022 | 195,000.00 |
| Jun 30, 2022 | 65,000.00 |
| Mar 31, 2022 | 127,000.00 |
| Dec 31, 2021 | 19,000.00 |
| Dec 31, 2020 | 25,000.00 |